VR and Scrip Training of PWA, Randomized Controlled Trial
VRSTPWA
Can Immersive Virtual Reality Magnify Treatment Outcomes of Script Training on Cantonese Speakers with Chronic Aphasia: a Randomized Controlled Trial
1 other identifier
interventional
105
0 countries
N/A
Brief Summary
The goal of this RCT is to investigate if computerized script training may promote functional communication and nonverbal cognitive functions of Cantonese-speaking PWA, and whether VR may further magnify the treatment outcomes. The main research questions are:
- 1.Can script training promote verbal functional communication of Cantonese-speaking PWA?
- 2.Can script training enhance nonverbal cognitive functions of Cantonese-speaking PWA?
- 3.Can VR magnify verbal and nonverbal treatment outcomes of script training of PWA?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2025
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 3, 2024
CompletedFirst Posted
Study publicly available on registry
December 9, 2024
CompletedStudy Start
First participant enrolled
June 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2028
March 13, 2025
August 1, 2024
2.5 years
December 3, 2024
March 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Percentage accuracy of treatment probe correctly produced
Participant's production accuracy of the trained scripts in read-aloud and no-cue conditions.
From baseline up to 8-week post training
Time to produce each of the scripts in the treatment probe
Participant's production time of the trained scripts in read-aloud and no-cue conditions.
From baseline up to 8-week post training
Number of sessions to reach performance criteria in session probe
From baseline up to 8-week post training
Secondary Outcomes (7)
Cantonese version of the Western Aphasia Battery (CAB) to measure aphasia severity
From baseline up to 8-week post training
Cantonese version of the Amsterdam-Nijmegen Everyday Language Test to measure verbal communication effectiveness in conversation via 20 culturally appropriate scenarios
From baseline up to 8-week post training
Cantonese version of the 20-item Communication Outcome after Stroke (Can-COAST) as a self-reported outcome on communication and quality of life
From baseline up to 8-week post training
Subtest 1 (map search) and 3 (elevator counting) of Test of Everyday Attention to assess attention
From baseline up to 8-week post training
Digit span forward and backward task to assess verbal short-term and working memory
From baseline up to 8-week post training
- +2 more secondary outcomes
Study Arms (3)
VR-based script training
EXPERIMENTALControl
NO INTERVENTIONComputerized script training without VR
ACTIVE COMPARATORInterventions
The PWA will wear a head-mounted VR device (e.g., Metaverse Oculus Quest 2 or other commercially available devices) for 30 minutes, which intends to create an immersive environment for training. Scripts trained in the computerized script training program in a particular session will be practiced. Cinematic 360˚ photo-real scenarios of daily contexts such as a restaurant or a grocery store will be displayed in the device while a communication partner, e.g., a waiter in the restaurant or a shopkeeper of a grocery store will initiate the conversation by producing the corresponding part of the script. The PWA will be given time to respond. Upon the completion of PWA's respond, the next conversational turn will be initiated. The clinical assistant, who accompanies the PWA in the entire training session, will control the flow of the 360 ˚ videos.
The flow of training is identical to the VR condition, except that photos depicting the scenarios and prerecorded conversational turns will be presented to the PWA on a computer screen with the same procedures mentioned in the VR condition.
Eligibility Criteria
You may qualify if:
- a stroke onset more than six months, with an Aphasia Quotient (AQ) below 96.4, as evaluated by the Cantonese version of Western Aphasia Battery (CAB; Yiu, 1992),
- premorbid fluent Cantonese speakers,
- aged between 30 and 80 years,
- no reported progressive neurogenic disorders such as dementia or Parkinson's disease,
- no motor speech disorders of moderate to severe level, and
- normal or corrected-to-normal vision and hearing functions
You may not qualify if:
- concurrent participation in other aphasia treatment trials, and
- incompatibility with immersive VR exposure such as complains of nausea, headache, or other severe discomforts during trial use of a head-mounted device during screening.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Hong Kong Polytechnic Universitylead
- Prof FONG NAI KUEN KENNETHcollaborator
- Dr LI SHI PUIcollaborator
- Dr NG HIU FUNG PETERcollaborator
- Johns Hopkins Universitycollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Winsy WS Wong, PhD
The Hong Kong Polytechnic University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 3, 2024
First Posted
December 9, 2024
Study Start
June 1, 2025
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
June 1, 2028
Last Updated
March 13, 2025
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Data will be shared starting from three months after manuscript publication.
- Access Criteria
- The IPD and study protocol will be shared in an open-access data repository without restrictions.
The IPD, together with the study protocol, will be shared in an open-access data repository (e.g., OSF).